Literature DB >> 20030415

Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment.

Eero Castrén1, Tomi Rantamäki.   

Abstract

Brain-derived neurotrophic factor (BDNF) is a critical mediator of activity-dependent neuronal plasticity in the cerebral cortex. Deficits in neurotrophic factors have been proposed to underlie mood disorders. However, recent evidence suggests that mood disorders may be produced by abnormalities in the adaptation of neural networks to environmental conditions. Antidepressants may act by enhancing neuronal plasticity, which allows environmental inputs to modify the neuronal networks to better fine tune the individual to the outside world. Recent observations in the visual cortex directly support this idea. According to the network hypothesis of depression, changes in the levels of neurotrophins including BDNF may not directly produce depression or an antidepressant effect, but neurotrophins may act as critical tools in the process whereby environmental conditions guide neuronal networks to better adapt to the environment. This hypothesis suggests that antidepressant drugs should not be used alone but should always be combined with rehabilitation to guide the plastic networks within the brain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20030415     DOI: 10.2165/11530010-000000000-00000

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  90 in total

Review 1.  Neurotrophins: roles in neuronal development and function.

Authors:  E J Huang; L F Reichardt
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 2.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

Review 3.  Mechanisms and functional implications of adult neurogenesis.

Authors:  Chunmei Zhao; Wei Deng; Fred H Gage
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

4.  Biosynthesis and processing of endogenous BDNF: CNS neurons store and secrete BDNF, not pro-BDNF.

Authors:  Tomoya Matsumoto; Stefanie Rauskolb; Martin Polack; Johannes Klose; Roland Kolbeck; Martin Korte; Yves-Alain Barde
Journal:  Nat Neurosci       Date:  2008-01-20       Impact factor: 24.884

5.  Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus.

Authors:  Tibor Hajszan; Neil J MacLusky; Csaba Leranth
Journal:  Eur J Neurosci       Date:  2005-03       Impact factor: 3.386

6.  TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment.

Authors:  Yun Li; Bryan W Luikart; Shari Birnbaum; Jian Chen; Chang-Hyuk Kwon; Steven G Kernie; Rhonda Bassel-Duby; Luis F Parada
Journal:  Neuron       Date:  2008-08-14       Impact factor: 17.173

7.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

8.  Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants.

Authors:  Cyril Rocher; Michael Spedding; Carmen Munoz; Thérèse M Jay
Journal:  Cereb Cortex       Date:  2004-02       Impact factor: 5.357

9.  Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling.

Authors:  Olivia F O'Leary; Xuefei Wu; Eero Castren
Journal:  Psychoneuroendocrinology       Date:  2008-11-01       Impact factor: 4.905

10.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus.

Authors:  H Kang; E M Schuman
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

View more
  38 in total

1.  Food, mood, and brain health: implications for the modern clinician.

Authors:  Laura Lachance; Drew Ramsey
Journal:  Mo Med       Date:  2015 Mar-Apr

Review 2.  Developmental risk I: depression and the developing brain.

Authors:  John M Weir; Arthurine Zakama; Uma Rao
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2012-02-17

3.  Serum BDNF levels before treatment predict SSRI response in depression.

Authors:  Owen M Wolkowitz; Jessica Wolf; Wendy Shelly; Rebecca Rosser; Heather M Burke; George K Lerner; Victor I Reus; J Craig Nelson; Elissa S Epel; Synthia H Mellon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-07-03       Impact factor: 5.067

4.  Behavioral and biochemical effects of ketamine and dextromethorphan relative to its antidepressant-like effects in Swiss Webster mice.

Authors:  Linda Nguyen; Brandon P Lucke-Wold; Aric F Logsdon; Anna L Scandinaro; Jason D Huber; Rae R Matsumoto
Journal:  Neuroreport       Date:  2016-09-28       Impact factor: 1.837

Review 5.  The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression.

Authors:  Gabriele Masi; Paola Brovedani
Journal:  CNS Drugs       Date:  2011-11-01       Impact factor: 5.749

6.  Modulation of DNA Methylation and Gene Expression in Rodent Cortical Neuroplasticity Pathways Exerts Rapid Antidepressant-Like Effects.

Authors:  Amanda J Sales; Izaque S Maciel; Angélica C D R Suavinha; Sâmia R L Joca
Journal:  Mol Neurobiol       Date:  2020-10-06       Impact factor: 5.590

7.  Cyclotraxin-B, the first highly potent and selective TrkB inhibitor, has anxiolytic properties in mice.

Authors:  Maxime Cazorla; Anne Jouvenceau; Christiane Rose; Jean-Philippe Guilloux; Catherine Pilon; Alex Dranovsky; Joël Prémont
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

8.  Environmental enrichment induces behavioral recovery and enhanced hippocampal cell proliferation in an antidepressant-resistant animal model for PTSD.

Authors:  Hendrikus Hendriksen; Jolanda Prins; Berend Olivier; Ronald S Oosting
Journal:  PLoS One       Date:  2010-08-05       Impact factor: 3.240

9.  The antidepressant fluoxetine mobilizes vesicles to the recycling pool of rat hippocampal synapses during high activity.

Authors:  Jasmin Jung; Kristina Loy; Eva-Maria Schilling; Mareike Röther; Jan M Brauner; Tobias Huth; Ursula Schlötzer-Schrehardt; Christian Alzheimer; Johannes Kornhuber; Oliver Welzel; Teja W Groemer
Journal:  Mol Neurobiol       Date:  2013-11-05       Impact factor: 5.590

10.  Kdm6b and Pmepa1 as Targets of Bioelectrically and Behaviorally Induced Activin A Signaling.

Authors:  Andrea S Link; Svitlana Kurinna; Steven Havlicek; Sandra Lehnert; Martin Reichel; Johannes Kornhuber; Beate Winner; Tobias Huth; Fang Zheng; Sabine Werner; Christian Alzheimer
Journal:  Mol Neurobiol       Date:  2015-07-28       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.